Evidence map›Paper›PMID 39838489›Full record

ArticleBreast cancer research : BCR2025

Obesity increases DNA damage in the breast epithelium.

Mohamed Gaber, Arnaud Quentel, Julia Holmes, Cassandra Lepetit, Hana Triki, Adam Wilson, Valerie Payne, Iliana Tenvooren, Cloé Dehours, Abigail Peoples and 7 more

Abstract read
In one paragraph

Article in Breast cancer research : BCR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Murine Models of Obesity-Related Cancer Risk.Cancer prevention research (Philadelphia, Pa.) · 2025
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mohamed GaberDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Arnaud QuentelInstitut de Cancérologie de l'Ouest, Angers, F-49055, France.
Julia HolmesDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Cassandra LepetitInstitut de Cancérologie de l'Ouest, Angers, F-49055, France.
Hana TrikiUniversité d'Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes Université, CRCI2NA, SFR ICAT, Angers, France.
Adam WilsonDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Valerie PayneDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Iliana TenvoorenDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Cloé DehoursInstitut de Cancérologie de l'Ouest, Angers, F-49055, France.
Abigail PeoplesDepartment of Plastic and Reconstructive Surgery, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Mary L DuetDepartment of Plastic and Reconstructive Surgery, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Adam J KatzDepartment of Plastic and Reconstructive Surgery, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Thierry PécotBiosit, UAR 3480 CNRS - US 18 Inserm, Rennes University, Rennes, F-35042, France.
Gwenola Bougras-CartronUniversité d'Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes Université, CRCI2NA, SFR ICAT, Angers, France.
Pierre-François CartronUniversité d'Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes Université, CRCI2NA, SFR ICAT, Angers, France.
Katherine L CookDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Pierre-Alexandre VidiDepartment of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA. pierre.vidi@ico.unicancer.fr.

Funding

Chan Zuckerberg Initiative 2019-198009Congressionally Directed Medical Research Programs BC170905Congressionally Directed Medical Research Programs BC190271Institut National Du Cancer PREV-BIO21-018
6 · The paper itself

Abstract

Obesity is a modifiable risk factor for breast cancer. Yet, how obesity contributes to cancer initiation is not fully understood. The goal of this study was to determine if the body mass index (BMI) and metabolic hallmarks of obesity are related to DNA damage in normal breast tissue. In a mouse model of diet-induced obesity, weight gain was associated with elevated levels of DNA double-strand breaks in the mammary gland. We also found a positive correlation between BMI and DNA breaks in the breast epithelium of premenopausal women (but not postmenopausal women). High BMI was associated with elevated systemic and tissue-level oxidative DNA damage across the lifespan, and we propose that the breast epithelium undergoing menstruous proliferation waves is particularly prone to the generation of DNA breaks from oxidative lesions. Ancestry was an important modulator of the obesity-DNA break connection. Compared to non-Hispanic Whites, women identifying as African Americans had higher levels of DNA breaks, as well as elevated leptin and IGF-1. In 3D cultures of breast acini, both leptin and IGF-1 caused an accumulation of DNA damage. The results highlight a connection between premalignant genomic alterations in the breast epithelium and metabolic health modulated by obesity and ancestry. They call for attention on biological determinants of breast cancer risk disparities.

Indexed as

BreastBreast NeoplasmsDNA DamageObesityAdultAnimalsBody Mass IndexDNA Breaks, Double-StrandedEpitheliumFemaleHumansInsulin-Like Growth Factor ILeptinMiceMiddle AgedPremenopauseInsulin-Like Growth Factor ILeptin3D cell cultureBreast cancer riskCancer health disparitiesDNA double-strand breaksIGF-1LeptinMolecular markersObesity

Identifiers

PMID39838489
PMCPMC11753040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.